Literature DB >> 19176701

The cardiotonic steroid hormone marinobufagenin induces renal fibrosis: implication of epithelial-to-mesenchymal transition.

Larisa V Fedorova1, Vanamala Raju, Nasser El-Okdi, Amjad Shidyak, David J Kennedy, Sandeep Vetteth, David R Giovannucci, Alexei Y Bagrov, Olga V Fedorova, Joseph I Shapiro, Deepak Malhotra.   

Abstract

We recently demonstrated that the cardiotonic steroid marinobufagenin (MBG) induced fibrosis in rat hearts through direct stimulation of collagen I secretion by cardiac fibroblasts. This stimulation was also responsible for the cardiac fibrosis seen in experimental renal failure. In this study, the effect of MBG on the development of renal fibrosis in rats was investigated. Four weeks of MBG infusion triggered mild periglomerular and peritubular fibrosis in the cortex and the appearance of fibrotic scars in the corticomedullary junction of the kidney. MBG also significantly increased the protein levels and nuclear localization of the transcription factor Snail in the tubular epithelia. It is known that activation of Snail is associated with epithelial-to-mesenchymal transition (EMT) during renal fibrosis. To examine whether MBG alone can trigger EMT, we used the porcine proximal tubular cell line LLC-PK1. MBG (100 nM) caused LLC-PK1 cells grown to confluence to acquire a fibroblast-like shape and have an invasive motility. The expressions of the mesenchymal proteins collagen I, fibronectin, and vimentin were increased twofold. However, the total level of E-cadherin remained unchanged. These alterations in LLC-PK1 cells in the presence of MBG were accompanied by elevated expression and nuclear translocation of Snail. During the time course of EMT, MBG did not have measurable inhibitory effects on the ion pumping activity of its natural ligand, Na(+)-K(+)-ATPase. Our data suggest that the MBG may be an important factor in inducing EMT and, through this mechanism, elevated levels of MBG in chronic renal failure may play a role in the progressive fibrosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19176701      PMCID: PMC3973402          DOI: 10.1152/ajprenal.90605.2008

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  94 in total

Review 1.  Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?

Authors:  Héctor Peinado; David Olmeda; Amparo Cano
Journal:  Nat Rev Cancer       Date:  2007-05-17       Impact factor: 60.716

Review 2.  Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.

Authors:  Wilhelm Schoner; Georgios Scheiner-Bobis
Journal:  Am J Physiol Cell Physiol       Date:  2007-05-09       Impact factor: 4.249

Review 3.  Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT?

Authors:  Derek C Radisky; Paraic A Kenny; Mina J Bissell
Journal:  J Cell Biochem       Date:  2007-07-01       Impact factor: 4.429

Review 4.  Reactivation of Snail genes in renal fibrosis and carcinomas: a process of reversed embryogenesis?

Authors:  Agnès Boutet; Miguel A Esteban; Patrick H Maxwell; M Angela Nieto
Journal:  Cell Cycle       Date:  2007-03-19       Impact factor: 4.534

5.  Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy.

Authors:  Jihad Elkareh; David J Kennedy; Belvadi Yashaswi; Sandeep Vetteth; Amjad Shidyak; Eric G R Kim; Sleiman Smaili; Sankaridrug M Periyasamy; Imad M Hariri; Larisa Fedorova; Jiang Liu; Liang Wu; M Bashar Kahaleh; Zijian Xie; Deepak Malhotra; Olga V Fedorova; Vladimir A Kashkin; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Hypertension       Date:  2006-12-04       Impact factor: 10.190

Review 6.  Diversity of LEF/TCF action in development and disease.

Authors:  L Arce; N N Yokoyama; M L Waterman
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

7.  A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells.

Authors:  Jong In Yook; Xiao-Yan Li; Ichiro Ota; Casey Hu; Hyun Sil Kim; Nam Hee Kim; So Young Cha; Joo Kyung Ryu; Yoon Jung Choi; Jin Kim; Eric R Fearon; Stephen J Weiss
Journal:  Nat Cell Biol       Date:  2006-10-29       Impact factor: 28.824

8.  Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition.

Authors:  Michael Zeisberg; Changqing Yang; Margot Martino; Michael B Duncan; Florian Rieder; Harikrishna Tanjore; Raghu Kalluri
Journal:  J Biol Chem       Date:  2007-06-11       Impact factor: 5.157

Review 9.  Endogenous and exogenous cardiac glycosides and their mechanisms of action.

Authors:  Wilhelm Schoner; Georgios Scheiner-Bobis
Journal:  Am J Cardiovasc Drugs       Date:  2007       Impact factor: 3.571

10.  Endogenous Na/K-ATPase inhibitors in patients with preeclampsia.

Authors:  I V Averina; N I Tapilskaya; V A Reznik; E V Frolova; O V Fedorova; E G Lakatta; A Y Bagrov
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2006-12-30       Impact factor: 1.770

View more
  34 in total

1.  Proinflammatory Effects of Cardiotonic Steroids Mediated by NKA α-1 (Na+/K+-ATPase α-1)/Src Complex in Renal Epithelial Cells and Immune Cells.

Authors:  Fatimah K Khalaf; Prabhatchandra Dube; Andrew L Kleinhenz; Deepak Malhotra; Amira Gohara; Christopher A Drummond; Jiang Tian; Steven T Haller; Zijian Xie; David J Kennedy
Journal:  Hypertension       Date:  2019-05-28       Impact factor: 10.190

2.  Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure.

Authors:  David J Kennedy; Kevin Shrestha; Brendan Sheehey; Xinmin S Li; Anuradha Guggilam; Yuping Wu; Michael Finucan; Alaa Gabi; Charles M Medert; Kristen Westfall; Allen Borowski; Olga Fedorova; Alexei Y Bagrov; W H Wilson Tang
Journal:  Circ Heart Fail       Date:  2015-08-14       Impact factor: 8.790

3.  A randomized trial of dietary sodium restriction in CKD.

Authors:  Emma J McMahon; Judith D Bauer; Carmel M Hawley; Nicole M Isbel; Michael Stowasser; David W Johnson; Katrina L Campbell
Journal:  J Am Soc Nephrol       Date:  2013-11-07       Impact factor: 10.121

Review 4.  Endogenous cardiotonic steroids in kidney failure: a review and an hypothesis.

Authors:  John M Hamlyn; Paolo Manunta
Journal:  Adv Chronic Kidney Dis       Date:  2015-05       Impact factor: 3.620

Review 5.  Endogenous cardiotonic steroids and salt-sensitive hypertension.

Authors:  Olga V Fedorova; Joseph I Shapiro; Alexei Y Bagrov
Journal:  Biochim Biophys Acta       Date:  2010-03-27

6.  Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease.

Authors:  Steven T Haller; Christopher A Drummond; Yanling Yan; Jiang Liu; Jiang Tian; Deepak Malhotra; Joseph I Shapiro
Journal:  Am J Hypertens       Date:  2013-09-06       Impact factor: 2.689

7.  High salt intake causes adverse fetal programming--vascular effects beyond blood pressure.

Authors:  Grzegorz Piecha; Nadezda Koleganova; Eberhard Ritz; Annett Müller; Olga V Fedorova; Alexei Y Bagrov; Diana Lutz; Peter Schirmacher; Marie-Luise Gross-Weissmann
Journal:  Nephrol Dial Transplant       Date:  2012-03-19       Impact factor: 5.992

8.  Na/K-ATPase/src complex mediates regulation of CD40 in renal parenchyma.

Authors:  Jeffrey X Xie; Shungang Zhang; Xiaoyu Cui; Jue Zhang; Hui Yu; Fatimah K Khalaf; Deepak Malhotra; David J Kennedy; Joseph I Shapiro; Jiang Tian; Steven T Haller
Journal:  Nephrol Dial Transplant       Date:  2018-07-01       Impact factor: 5.992

9.  Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target.

Authors:  X Fan; J Xie; J Tian
Journal:  Cardiovasc Pharm Open Access       Date:  2017-01-31

10.  Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.

Authors:  Olga V Fedorova; Natalia I Tapilskaya; Anton M Bzhelyansky; Elena V Frolova; Elena R Nikitina; Vitaly A Reznik; Vladimir A Kashkin; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.